Janet Krevolin is the Chief Technical Officer at privately-held medical device company Bio2 Technologies, Inc. She is currently working on commercialization of Bio2's Vitrium® platform technology. She has over 25 years experience in medical device research and product development. Her career has focused on R&D of medical devices, with particular attention to the musculo-skeletal system. She has been a professor of the practice in the Department of Biomedical Engineering since 2016.
Professor of the Practice, Department of Biomedical Engineering, Tufts School of Engineering
Chief Technical Officer, Bio2 Technologies
Vice President of Orthopedic Product Development, Bio2 Technologies
Vice President of Global Product Development, Zimmer Inc.
Vice President of Research Europe, Zimmer GmbH
Director of Research Europe, Zimmer GmbH
Janet Krevolin's research interests include medical device design and development, most recently developing products using bioactive glass fibers and a proprietary manufacturing process to produce, for the first time, a resorbable construct that has the initial strength necessary to be load-bearing while stimulating new bone formation. She works with surgeons and clinicians to address unmet clinical needs, translate these unmet needs into a medical device, obtain regulatory (FDA, CE) clearance, and commercialize the product.